🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors market the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking fines, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has removed violative content and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive reviews and detailed guides for preparing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Information and Costs

Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly significant medical dangers”.